The structure of Ras protein: a model for a universal molecular switch
- PMID: 1785141
- DOI: 10.1016/0968-0004(91)90156-p
The structure of Ras protein: a model for a universal molecular switch
Abstract
X-ray crystallography has revealed the molecular architecture of the cellular and oncogenic forms of p21Ha-ras, the protein encoded by the human Ha-ras gene, in both its active (GTP-bound) and in its inactive (GDP-bound) forms. From comparison of these two structures, a mechanism is suggested for the GTPase hydrolysis reaction that triggers the conformational change necessary for signal transduction. The structures have also allowed identification of the structural consequences of point mutations and the way in which they interfere with the intrinsic GTPase activity of p21ras. The p21ras structure is similar to that of the G-domain of elongation factor Tu (EF-Tu) from Escherichia coli, suggesting that p21ras can serve as a good model for other guanine nucleotide binding proteins.
Similar articles
-
Linear free energy relationships in the intrinsic and GTPase activating protein-stimulated guanosine 5'-triphosphate hydrolysis of p21ras.Biochemistry. 1996 Nov 12;35(45):14225-31. doi: 10.1021/bi961118o. Biochemistry. 1996. PMID: 8916907
-
Three-dimensional structure and properties of wild-type and mutant H-ras-encoded p21.Ciba Found Symp. 1993;176:6-21; discussion 21-7. doi: 10.1002/9780470514450.ch2. Ciba Found Symp. 1993. PMID: 8299426 Review.
-
Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase.J Biol Chem. 1995 Feb 17;270(7):2901-5. doi: 10.1074/jbc.270.7.2901. J Biol Chem. 1995. PMID: 7852367
-
Three-dimensional structure of p21H-ras and its implications.Semin Cancer Biol. 1992 Aug;3(4):189-98. Semin Cancer Biol. 1992. PMID: 1421163 Review.
-
Guanine-nucleotide binding activity, interaction with GTPase-activating protein and solution conformation of the human c-Ha-Ras protein catalytic domain are retained upon deletion of C-terminal 18 amino acid residues.J Protein Chem. 1992 Dec;11(6):731-9. doi: 10.1007/BF01024974. J Protein Chem. 1992. PMID: 1466766
Cited by
-
Mapping protein conformational landscapes from crystallographic drug fragment screens.bioRxiv [Preprint]. 2024 Jul 30:2024.07.29.605395. doi: 10.1101/2024.07.29.605395. bioRxiv. 2024. Update in: J Chem Inf Model. 2024 Nov 12. doi: 10.1021/acs.jcim.4c01380 PMID: 39131376 Free PMC article. Updated. Preprint.
-
Next-generation therapies for pancreatic cancer.Expert Rev Gastroenterol Hepatol. 2024 Jan-Feb;18(1-3):55-72. doi: 10.1080/17474124.2024.2322648. Epub 2024 Feb 28. Expert Rev Gastroenterol Hepatol. 2024. PMID: 38415709 Review.
-
RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming.Curr Treat Options Oncol. 2023 Aug;24(8):1088-1101. doi: 10.1007/s11864-023-01096-x. Epub 2023 Jun 10. Curr Treat Options Oncol. 2023. PMID: 37296367 Review.
-
Inhibition of mutant RAS-RAF interaction by mimicking structural and dynamic properties of phosphorylated RAS.Elife. 2022 Dec 2;11:e79747. doi: 10.7554/eLife.79747. Elife. 2022. PMID: 36458814 Free PMC article.
-
Characterization of the binding of MRTX1133 as an avenue for the discovery of potential KRASG12D inhibitors for cancer therapy.Sci Rep. 2022 Oct 22;12(1):17796. doi: 10.1038/s41598-022-22668-1. Sci Rep. 2022. PMID: 36273239 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous